Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile
Marcos Cruces Olivar; Allan D. Burboa; Yolanda M. Gómez;
Reumatol Clin. 2025;21:
Survey to evaluate exposure to environmental factors in patients with rheumatoid arthritis
Alexandra Zúñiga; Alba Luz León Álvarez; Luisa Carbal-Reyes; Daniel Rodríguez; Juan-Camilo Díaz; Gloria Vásquez; Diana Castaño;
Reumatol Clin. 2025;21:
Association of electrocardiographic altered P wave dispersion and vascular endothelial growth factor in rheumatoid arthritis
Osmar Antonio Centurión; Paloma de Abreu; Gabriela Avila-Pedretti; Sonia R. Cabrera; María T. Martínez de Filártiga; Astrid Paats; Judith M. Torales; Christian O. Chávez; Carmen R. Montiel; Laura B. García; Karina E. Scavenius; Rocío del Pilar Falcón; Jose C. Candia; Alfredo J. Meza; Isabel Acosta-Colmán;
Reumatol Clin. 2025;21: